| Expression level and clinical significance of NBAT-1 in human cancers: a systematic review and meta-analysis. | Expression level and clinical significance of NBAT-1 in human cancers: a systematic review and meta-analysis.
Yu Y, Fan K, Ni T, Zhang XL, Su X, Yang L., Free PMC Article | 02/1/2024 |
| Serum lncRNAs, NBAT-1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C. | Serum lncRNAs, NBAT-1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C.
Ali MA, Shaker OG, Ezzat EM, Eid HM, Ali DY, Hassan EA, Elsayed DH, Abozaid ER, Abdelaleem OO. | 02/28/2023 |
| Long noncoding RNA NBAT1 suppresses hepatocellular carcinoma progression via competitively associating with IGF2BP1 and decreasing c-Myc expression. | Long noncoding RNA NBAT1 suppresses hepatocellular carcinoma progression via competitively associating with IGF2BP1 and decreasing c-Myc expression.
Wei L, Ling M, Yang S, Xie Y, Liu C, Yi W. | 08/7/2021 |
| Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma. | Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma.
Mitra S, Muralidharan SV, Di Marco M, Juvvuna PK, Kosalai ST, Reischl S, Jachimowicz D, Subhash S, Raimondi I, Kurian L, Huarte M, Kogner P, Fischer M, Johnsen JI, Mondal T, Kanduri C. | 06/26/2021 |
| Expression of long noncoding RNA NBAT1 is associated with the outcome of patients with non-small cell lung cancer. | Expression of long noncoding RNA NBAT1 is associated with the outcome of patients with non-small cell lung cancer.
Wang DL, Yuan P, Tian JY. | 09/12/2020 |
| Low NBAT1 expression is associated with cell proliferation, migration, and invasion in renal carcinoma. | LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.
Xue S, Wang S, Li J, Guan H, Jiang S, Guo Y, Li Q. | 06/6/2020 |
| NBAT-1 overexpression remarkably upregulated PTEN expression in gastric cancer (GC) cells. Low expression of NBAT-1 promotes GC development by downregulating PTEN expression. | Low expression of lncRNA NBAT-1 promotes gastric cancer development and is associated with poor prognosis.
Gao Y, Chen J. | 12/28/2019 |
| Up-regulation of NBAT1 inhibited proliferative activities of glioblastoma tumor cells by regulating Akt activity. | Effect of downregulated lncRNA NBAT1 on the biological behavior of glioblastoma cells.
Liu J, Wang WM, Zhang XL, Du QH, Li HG, Zhang Y. | 12/14/2019 |
| The overexpression of lncRNA NBAT-1 could inhibit the proliferation and cell cycle, promote the apoptosis of A549 cells, and down-regulate the expression level of RAC1. | LncRNA NBAT-1 is down-regulated in lung cancer and influences cell proliferation, apoptosis and cell cycle.
Lei T, Lv ZY, Fu JF, Wang Z, Fan Z, Wang Y. | 11/9/2019 |
| DKK1 is found to be regulated by NBAT1 in a PRC2 dependent manner, and is responsible for NBAT1's effects in inhibiting migration and invasion of breast cancer cells. | NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.
Hu P, Chu J, Wu Y, Sun L, Lv X, Zhu Y, Li J, Guo Q, Gong C, Liu B, Su S., Free PMC Article | 08/13/2016 |
| Loss of NBAT-1 contributes to aggressive neuroblastoma by increasing proliferation and impairing differentiation of neuronal precursors. | The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.
Pandey GK, Mitra S, Subhash S, Hertwig F, Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S, Ostensson M, Akyürek LM, Abrahamsson J, Pfeifer S, Larsson E, Shi L, Peng Z, Fischer M, Martinsson T, Hedborg F, Kogner P, Kanduri C. | 02/14/2015 |